Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study (scientific article published on 03 April 2013)

Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder pa

Q28238749

Neuroactive steroids: focus on human brain

Q28241682

White matter development in adolescence: a DTI study

Q28269442

Multiple imputation of discrete and continuous data by fully conditional specification

Q31118138

Correlations between cortisol level and internalizing disposition of young children are increased by selecting optimal sampling times and aggregating data

Q31120885

Missing data analysis: making it work in the real world

Q31165001

Stress regulation in the central nervous system: evidence from structural and functional neuroimaging studies in human populations - 2008 Curt Richter Award Winner

Q33429405

An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies.

Q33572408

Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis

Q49084017

Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis.

Q49134812

Increased stress-induced dopamine release in psychosis.

Q50777739

Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics.

Q51466633

Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.

Q51935063

Serum cortisol and dehydroepiandrosterone-sulfate levels in schizophrenic patients and their first-degree relatives

Q84899068

Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume

Q33849008

Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability

Q34301805

Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome

Q34398230

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America

Q34586836

Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth

Q34639853

A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa.

Q34779170

Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function

Q34956577

Cortical thickness reduction in individuals at ultra-high-risk for psychosis

Q35065370

The impact of sex, puberty, and hormones on white matter microstructure in adolescents

Q36142316

Role of glucocorticoids in dopamine-related neuropsychiatric disorders

Q36323821

North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment

Q36412920

Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis

Q36442025

Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment

Q36442033

Prospective investigations of the prodromal state of schizophrenia: assessment instruments

Q36459559

Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice

Q36524739

Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia

Q37120692

Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression

Q37328137

Sex steroids and brain structure in pubertal boys and girls: a mini-review of neuroimaging studies

Q37844967

Endocrine modulation of the adolescent brain: a review

Q37868152

Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis

Q37935296

Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with "at risk" mental state

Q38015914

Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia.

Q39791733

Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis

Q40404354

A corticosteroid/dopamine hypothesis for psychotic depression and related states

Q41339617

SRD5A2 is associated with increased cortisol metabolism in schizophrenia spectrum disorders

Q42924001

Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research

Q43789984

Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.

Q44740423

White matter abnormalities in subjects at ultra high-risk for schizophrenia and first-episode schizophrenic patients.

Q45227174

Identification of the functional domain of glucocorticoid receptor involved in RU486 antagonism.

Q45918609

Cortisol circadian rhythm alterations in psychotic major depression

Q46508647

Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study

Q46816217

HPA axis functioning associated with transition to psychosis: combined DEX/CRH test

Q46887505

The relation of cortisol levels with hippocampus volumes under baseline and challenge conditions

Q46950698

Differential effects of stress on [11C]raclopride and [11C]MNPA binding to striatal D2/D3 dopamine receptors: A PET study in conscious monkeys

Q48099433

Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder

Q48238062

Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress

Q48251731

Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development

Q48263254

Structural and functional brain correlates of subclinical psychotic symptoms in 11-13 year old schoolchildren

Q48453745

Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders

Q48459917

Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis

Q48462840

Stress and HPA-axis functioning in young people at ultra high risk for psychosis

Q48475359

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

psychosis